Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA

Yuhua Li, Shifeng Wang, Giorgio Scarpellini, Bronwyn Gunn, Wei Xin, Soo Young Wanda, Kenneth L. Roland, Roy Curtiss

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Increasing the immunogenicity to delivered antigens by recombinant attenuated Salmonella vaccines (RASV) has been the subject of intensive study. With this goal in mind, we have designed and constructed a new generation of RASV that exhibit regulated delayed attenuation. These vaccine strains are phenotypically wild type at the time of immunization and become attenuated after colonization of host tissues. The vaccine strains are grown under conditions that allow expression of genes required for optimal invasion and colonization of host tissues. Once established in the host, these virulence genes are turned off, fully attenuating the vaccine strain. In this study, we compared 2 of our newly developed regulated delayed attenuation Salmonella enterica serovar Typhimurium strains χ9088 and χ9558 with the Δcya Δcrp Δasd strain χ8133, for their abilities to express and present a secreted form of the α-helical region of pneumococcal surface protein A (PspA) to the mouse immune system. All 3 strains induced high levels of serum antibodies specific for PspA as well as to Salmonella antigens in orally immunized mice. However, both RASVs expressing delayed attenuation elicited significantly greater anti-PspA immune responses, including serum IgG and T cell secretion of IL-4 and IFN-γ, than other groups. Also, vaccination with delayed attenuation strains resulted in a greater degree of protection against Streptococcus pneumoniae challenge than in mice vaccinated with χ8133 (71-86% vs. 21% survival, P ≤ 0.006). Together, the results demonstrate that the regulated attenuation strategy results in highly immunogenic antigen delivery vectors for oral vaccination.

Original languageEnglish (US)
Pages (from-to)593-598
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number2
DOIs
StatePublished - Jan 13 2009

Fingerprint

Salmonella enterica
Salmonella Vaccines
Attenuated Vaccines
Synthetic Vaccines
Vaccines
Antigens
Vaccination
Streptococcus pneumoniae
Serum
Salmonella
Interleukin-4
Virulence
Immune System
Immunization
Immunoglobulin G
T-Lymphocytes
Gene Expression
Antibodies
Genes
pneumococcal surface protein A

Keywords

  • Bacterial vectors
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • General

Cite this

Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. / Li, Yuhua; Wang, Shifeng; Scarpellini, Giorgio; Gunn, Bronwyn; Xin, Wei; Wanda, Soo Young; Roland, Kenneth L.; Curtiss, Roy.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 2, 13.01.2009, p. 593-598.

Research output: Contribution to journalArticle

Li, Yuhua ; Wang, Shifeng ; Scarpellini, Giorgio ; Gunn, Bronwyn ; Xin, Wei ; Wanda, Soo Young ; Roland, Kenneth L. ; Curtiss, Roy. / Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. In: Proceedings of the National Academy of Sciences of the United States of America. 2009 ; Vol. 106, No. 2. pp. 593-598.
@article{ff3d8ff440404749b463b8b7a05470ef,
title = "Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA",
abstract = "Increasing the immunogenicity to delivered antigens by recombinant attenuated Salmonella vaccines (RASV) has been the subject of intensive study. With this goal in mind, we have designed and constructed a new generation of RASV that exhibit regulated delayed attenuation. These vaccine strains are phenotypically wild type at the time of immunization and become attenuated after colonization of host tissues. The vaccine strains are grown under conditions that allow expression of genes required for optimal invasion and colonization of host tissues. Once established in the host, these virulence genes are turned off, fully attenuating the vaccine strain. In this study, we compared 2 of our newly developed regulated delayed attenuation Salmonella enterica serovar Typhimurium strains χ9088 and χ9558 with the Δcya Δcrp Δasd strain χ8133, for their abilities to express and present a secreted form of the α-helical region of pneumococcal surface protein A (PspA) to the mouse immune system. All 3 strains induced high levels of serum antibodies specific for PspA as well as to Salmonella antigens in orally immunized mice. However, both RASVs expressing delayed attenuation elicited significantly greater anti-PspA immune responses, including serum IgG and T cell secretion of IL-4 and IFN-γ, than other groups. Also, vaccination with delayed attenuation strains resulted in a greater degree of protection against Streptococcus pneumoniae challenge than in mice vaccinated with χ8133 (71-86{\%} vs. 21{\%} survival, P ≤ 0.006). Together, the results demonstrate that the regulated attenuation strategy results in highly immunogenic antigen delivery vectors for oral vaccination.",
keywords = "Bacterial vectors, Streptococcus pneumoniae",
author = "Yuhua Li and Shifeng Wang and Giorgio Scarpellini and Bronwyn Gunn and Wei Xin and Wanda, {Soo Young} and Roland, {Kenneth L.} and Roy Curtiss",
year = "2009",
month = "1",
day = "13",
doi = "10.1073/pnas.0811697106",
language = "English (US)",
volume = "106",
pages = "593--598",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "2",

}

TY - JOUR

T1 - Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA

AU - Li, Yuhua

AU - Wang, Shifeng

AU - Scarpellini, Giorgio

AU - Gunn, Bronwyn

AU - Xin, Wei

AU - Wanda, Soo Young

AU - Roland, Kenneth L.

AU - Curtiss, Roy

PY - 2009/1/13

Y1 - 2009/1/13

N2 - Increasing the immunogenicity to delivered antigens by recombinant attenuated Salmonella vaccines (RASV) has been the subject of intensive study. With this goal in mind, we have designed and constructed a new generation of RASV that exhibit regulated delayed attenuation. These vaccine strains are phenotypically wild type at the time of immunization and become attenuated after colonization of host tissues. The vaccine strains are grown under conditions that allow expression of genes required for optimal invasion and colonization of host tissues. Once established in the host, these virulence genes are turned off, fully attenuating the vaccine strain. In this study, we compared 2 of our newly developed regulated delayed attenuation Salmonella enterica serovar Typhimurium strains χ9088 and χ9558 with the Δcya Δcrp Δasd strain χ8133, for their abilities to express and present a secreted form of the α-helical region of pneumococcal surface protein A (PspA) to the mouse immune system. All 3 strains induced high levels of serum antibodies specific for PspA as well as to Salmonella antigens in orally immunized mice. However, both RASVs expressing delayed attenuation elicited significantly greater anti-PspA immune responses, including serum IgG and T cell secretion of IL-4 and IFN-γ, than other groups. Also, vaccination with delayed attenuation strains resulted in a greater degree of protection against Streptococcus pneumoniae challenge than in mice vaccinated with χ8133 (71-86% vs. 21% survival, P ≤ 0.006). Together, the results demonstrate that the regulated attenuation strategy results in highly immunogenic antigen delivery vectors for oral vaccination.

AB - Increasing the immunogenicity to delivered antigens by recombinant attenuated Salmonella vaccines (RASV) has been the subject of intensive study. With this goal in mind, we have designed and constructed a new generation of RASV that exhibit regulated delayed attenuation. These vaccine strains are phenotypically wild type at the time of immunization and become attenuated after colonization of host tissues. The vaccine strains are grown under conditions that allow expression of genes required for optimal invasion and colonization of host tissues. Once established in the host, these virulence genes are turned off, fully attenuating the vaccine strain. In this study, we compared 2 of our newly developed regulated delayed attenuation Salmonella enterica serovar Typhimurium strains χ9088 and χ9558 with the Δcya Δcrp Δasd strain χ8133, for their abilities to express and present a secreted form of the α-helical region of pneumococcal surface protein A (PspA) to the mouse immune system. All 3 strains induced high levels of serum antibodies specific for PspA as well as to Salmonella antigens in orally immunized mice. However, both RASVs expressing delayed attenuation elicited significantly greater anti-PspA immune responses, including serum IgG and T cell secretion of IL-4 and IFN-γ, than other groups. Also, vaccination with delayed attenuation strains resulted in a greater degree of protection against Streptococcus pneumoniae challenge than in mice vaccinated with χ8133 (71-86% vs. 21% survival, P ≤ 0.006). Together, the results demonstrate that the regulated attenuation strategy results in highly immunogenic antigen delivery vectors for oral vaccination.

KW - Bacterial vectors

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=58849132311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849132311&partnerID=8YFLogxK

U2 - 10.1073/pnas.0811697106

DO - 10.1073/pnas.0811697106

M3 - Article

C2 - 19114649

AN - SCOPUS:58849132311

VL - 106

SP - 593

EP - 598

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 2

ER -